- Home
- VRTX vs SHW Comparison
VRTX vs SHW Comparison
Compare VRTX & SHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRTX | SHW |
|---|---|---|
| Founded | 1989 | 1866 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | RETAIL: Building Materials |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.6B | 85.2B |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRTX | SHW |
|---|---|---|
| Price | $462.91 | $338.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 13 |
| Target Price | ★ $492.57 | $389.08 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 11-03-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 1.96 |
| EPS | ★ 14.22 | 10.23 |
| Revenue | $11,723,300,000.00 | ★ $23,275,600,000.00 |
| Revenue This Year | $11.01 | $2.50 |
| Revenue Next Year | $8.74 | $4.93 |
| P/E Ratio | ★ $32.56 | $33.16 |
| Revenue Growth | ★ 10.33 | 0.96 |
| 52 Week Low | $362.50 | $308.84 |
| 52 Week High | $519.68 | $398.00 |
Technical Indicators
Market Signals| Indicator | VRTX | SHW |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 50.47 |
| Support Level | $423.46 | $335.85 |
| Resistance Level | $434.67 | $344.80 |
| Average True Range (ATR) | 10.65 | 6.60 |
| MACD | 1.55 | 0.73 |
| Stochastic Oscillator | 98.79 | 75.23 |
Price Performance
Historical ComparisonAbout VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About SHW Sherwin-Williams Company (The)
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.